His primary areas of study are Surgery, Internal medicine, Hepatectomy, Survival rate and Oncology. His study connects Cancer and Surgery. Internal medicine is often connected to Gastroenterology in his work.
As a part of the same scientific study, Timothy M. Pawlik usually deals with the Hepatectomy, concentrating on Radiology and frequently concerns with Clinical trial. His work is dedicated to discovering how Survival rate, Surgical oncology are connected with Surgical resection and other disciplines. His work in Oncology tackles topics such as Lymph node which are related to areas like Lymph.
The scientist’s investigation covers issues in Internal medicine, Surgery, Gastroenterology, Oncology and Resection. His study in Internal medicine concentrates on Hepatocellular carcinoma, Cancer, Survival rate, Surgical oncology and Hazard ratio. The study incorporates disciplines such as Metastasis and Incidence in addition to Surgery.
His Gastroenterology research is multidisciplinary, incorporating perspectives in Proportional hazards model and Cohort. As part of one scientific family, Timothy M. Pawlik deals mainly with the area of Oncology, narrowing it down to issues related to the Adenocarcinoma, and often Pancreatic cancer. His work carried out in the field of Resection brings together such families of science as Radiology and General surgery.
Internal medicine, Resection, Surgical oncology, Cancer and Surgery are his primary areas of study. The concepts of his Internal medicine study are interwoven with issues in Gastroenterology, Hepatectomy and Oncology. In his study, Metastasis is inextricably linked to Radiology, which falls within the broad field of Resection.
His Surgical oncology research includes elements of MEDLINE and General surgery. His Cancer research incorporates themes from Odds ratio, Stage, Family medicine and Confidence interval. His study in Surgery is interdisciplinary in nature, drawing from both Logistic regression and Medicare beneficiary.
Timothy M. Pawlik mainly focuses on Internal medicine, Surgery, Resection, Gastroenterology and Hepatocellular carcinoma. He combines subjects such as Hepatectomy and Oncology with his study of Internal medicine. Timothy M. Pawlik studied Surgery and Medicare beneficiary that intersect with Surgeon volume.
His Resection study integrates concerns from other disciplines, such as Early Recurrence, Survival analysis and Overall survival. His research in Gastroenterology intersects with topics in Tumor size, External validation, Hepatitis B virus and Hazard ratio. His biological study spans a wide range of topics, including Lymphovascular invasion, Late Recurrence, Milan criteria and Cohort.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Chemotherapy regimen predicts steatohepatitis and an increase in 90-day mortality after surgery for hepatic colorectal metastases
Jean Nicolas Vauthey;Timothy M. Pawlik;Dario Ribero;Tsung Teh Wu.
Journal of Clinical Oncology (2006)
Effect of Surgical Margin Status on Survival and Site of Recurrence After Hepatic Resection for Colorectal Metastases
Timothy M. Pawlik;Charles R. Scoggins;Daria Zorzi;Eddie K. Abdalla.
Annals of Surgery (2005)
Role of cell cycle in mediating sensitivity to radiotherapy.
Timothy M. Pawlik;Khandan Keyomarsi.
International Journal of Radiation Oncology Biology Physics (2004)
Guidelines for the diagnosis and management of intrahepatic cholangiocarcinoma
John Bridgewater;Peter R. Galle;Shahid A. Khan;Josep M. Llovet;Josep M. Llovet.
Journal of Hepatology (2014)
Rates and patterns of recurrence following curative intent surgery for colorectal liver metastasis: an international multi-institutional analysis of 1669 patients.
Mechteld C. de Jong;Carlo Pulitano;Dario Ribero;Jennifer Strub.
Annals of Surgery (2009)
Expanding criteria for resectability of colorectal liver metastases
Timothy M. Pawlik;Richard D. Schulick;Michael A. Choti.
Tumor size predicts vascular invasion and histologic grade: Implications for selection of surgical treatment for hepatocellular carcinoma
Timothy M. Pawlik;Keith A. Delman;Jean‐Nicolas Vauthey;David M. Nagorney.
Liver Transplantation (2005)
Chemotherapy-associated hepatotoxicity and surgery for colorectal liver metastases
D. Zorzi;A. Laurent;T.M. Pawlik;G.Y. Lauwers.
British Journal of Surgery (2007)
Tumor size predicts vascular invasion and histologic grade
Eddie Abdalla;Timothy Pawlik;Keith Delman;Nicolas Vauthey.
Intrahepatic Cholangiocarcinoma: An International Multi-Institutional Analysis of Prognostic Factors and Lymph Node Assessment
Mechteld C. De Jong;Hari Nathan;Georgios C. Sotiropoulos;Andreas Paul.
Journal of Clinical Oncology (2011)
Surgical Oncology Clinics of North America
(Impact Factor: 2.402)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: